Skip to main content
Clinical and Translational Allergy logoLink to Clinical and Translational Allergy
. 2014 Mar 14;4(Suppl 1):O14. doi: 10.1186/2045-7022-4-S1-O14

O14 - Der p 10 as a minor allergen in children sensitised to house dust mites

Isabel Lafuente 1,, Raquel Pina 1, Sonia Uixera 1, Rafael Calderon 1, Isidoro Cortell 1, Juan Lopez 1, Antonio Nieto 1, Angel Mazon 1
PMCID: PMC4094286

Objective

To assess the proportion of children with specific IgE to Der p 10 in children with sensitization to house dust mites (HDM).

Material and methods

We determined specific IgE (ImmunoCAP®, Thermo Fisher Scientific) to Der p 1, Der p 2 and Der p 10 simultaneously in children with symptoms of asthma and/or rhinoconjunctivitis who had positive skin tests to HDM. Values <0.35 kUA/L were considered negative.

Results

We studied 232 children (147 M/85 F) aged 1.25 - 16.7 years. Negative results were found in 50 (21.6%) with Der p 1, 53 (22.8%) with Der p 2, 208 (89.7%) with Der p 10, and 29 with all three (12.5%). There were 24 patients with positive IgE to Der p 10: three of these had IgE values of 6.1 to 11 kUA/L to Der p 10 and negative results to Der p 1 and 2 (0.1 to 0.18), three had much higher IgE to Der p 10 (79.9 to >100) than to Der p 1 or 2 (0,58 to 24.2), and one slightly higher IgE to Der p 10 (2.8) than to Der p 1 or 2 (0.8 and 1.19). The rest of the patients had clearly lower IgE to Der p 10.

Conclusion

About 10% of patients sensitized to HDM had specific IgE to Der p 10. Sensitization to Der p 10 without sensitization to major allergens Der p 1 and Der p 2 appeared in 1.3% of patients, and serologically more relevant sensitization to Der p 10 in an additional 1.3% of patients. This should be considered when prescribing immunotherapy, as Der p 10 is not standardized in current vaccines.


Articles from Clinical and Translational Allergy are provided here courtesy of Wiley

RESOURCES